Literature DB >> 10332775

Laparoscopic adrenalectomy for cancer.

B T Heniford1, M J Arca, R M Walsh, I S Gill.   

Abstract

We will review the literature on the operative techniques and patient outcomes of laparoscopic adrenalectomy for cancer. Further, in our own study, an analysis of the preoperative assessment, operative, and hospital course, and postoperative follow-up was performed on all patients undergoing a laparoscopic adrenalectomy for cancer or metastasis from October 1996 through February 1998. Twelve laparoscopic resections were performed in 11 patients. There were six males and five females with an average age of 62 years (range, 40 to 79). The mean American Society of Anesthesiologists (ASA) score was 3.1 (range, 2 to 4). All of the tumors except one were due to metastatic cancer. The metastatic sources included renal cell cancer (four), lung cancer (two), colon cancer (two), adrenal cancer (one), and melanoma (one). Seven patients required a left adrenalectomy, three underwent a right adrenalectomy, and one was bilateral. The approach was transperitoneal in eight cases and retroperitoneal in four. The mean size of the tumors was 5.9 cm (range, 1.8 to 12 cm). Operative time averaged 181 minutes (range, 100 to 315 minutes), and blood loss was 138 cc (range, 20 to 1,300 cc). Average hospital stay was 2.3 days (range, < 1 to 6 days). One patient required conversion to an open approach due to local invasion of the tumor into the lateral wall of the vena cava, which was resected with the specimen. This procedure resulted in the largest blood loss of the series (1,300 cc). All specimens had negative surgical margins. There was one complication (9%), a laceration of the epigastric artery, which was controlled laparoscopically. At a mean follow-up of 8.3 months (range, 0.5 to 19 months), there have been no port site or local recurrences. One patient has developed a new hepatic nodule, which is being worked up for metastatic disease. Ten of the 11 patients (91%) are currently alive; one has died of expansive cerebral metastases from melanoma.

Entities:  

Mesh:

Year:  1999        PMID: 10332775     DOI: 10.1002/(sici)1098-2388(199906)16:4<293::aid-ssu4>3.0.co;2-e

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  40 in total

1.  The influence of new technologies on laparoscopic adrenalectomy: our personal experience with 91 patients.

Authors:  A Valeri; A Borrelli; L Presenti; M Lucchese; G Manca; P Tonelli; C Bergamini; D Borrelli; M Palli; C Saieva
Journal:  Surg Endosc       Date:  2002-05-07       Impact factor: 4.584

Review 2.  [The value of laparoscopic kidney surgery in urology].

Authors:  A Jurczok; A Hamza; A Nill; H-P Gerbershagen; P Fornara
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 3.  Minimal access adrenal surgery.

Authors:  L M Brunt
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

4.  Outcome of Laparoscopic Adrenalectomy in Obese Patients.

Authors:  Diana Paun; Rodica Petris; Roxana Ganescu; Sorin Paun; Mihaela Vartic; Mircea Beuran
Journal:  Maedica (Buchar)       Date:  2015-09

5.  SAGES guidelines for minimally invasive treatment of adrenal pathology.

Authors:  Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

6.  Adrenal metastectomy is safe in selected patients.

Authors:  Minerva Angelica Romero Arenas; Dawen Sui; Elizabeth G Grubbs; Jeffrey E Lee; Nancy D Perrier
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

Review 7.  Adrenocortical carcinoma: which surgical approach?

Authors:  Bruno Carnaille
Journal:  Langenbecks Arch Surg       Date:  2011-09-27       Impact factor: 3.445

8.  Laparoscopic adrenal metastasectomy: appropriate, safe, and feasible.

Authors:  Judy Y R Chen; Ali Ardestani; Ali Tavakkoli
Journal:  Surg Endosc       Date:  2013-12-14       Impact factor: 4.584

Review 9.  Surgical management of adrenal metastases.

Authors:  Juan J Sancho; Frédéric Triponez; Xavier Montet; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2011-12-16       Impact factor: 3.445

10.  Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.

Authors:  George N Zografos; George K Vasiliadis; Flora Zagouri; Chrysanthi Aggeli; Dimitris Korkolis; Sophia Vogiaki; Matina K Pagoni; Gregory Kaltsas; George Piaditis
Journal:  World J Surg Oncol       Date:  2010-03-10       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.